Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis

Published:2007-08-20 Issue:5 Volume:179 Page:3268-3275
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Fitzgerald Denise C.,Ciric Bogoljub,Touil Tarik,Harle Heather,Grammatikopolou Julia,Sarma Jayasri Das,Gran Bruno,Zhang Guang-Xian,Rostami Abdolmohamad

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

2. IMMUNOLOGY OF MULTIPLE SCLEROSIS

3. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

4. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases;Frontiers in Immunology;2024-08-15

2. IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10;The Journal of Immunology;2024-07-08

3. Targeted DeSUMOylation as a therapeutic strategy for multiple sclerosis;Journal of Neuroimmunology;2024-07

4. Potential therapeutic and diagnostic approaches of exosomes in multiple sclerosis pathophysiology;Life Sciences;2024-06

5. Adipose‐derived mesenchymal stem cells ameliorates experimental autoimmune encephalomyelitis via modulation of Th1/Th17 and expansion of Th2/Treg responses;Cell Biology International;2024-05-14